Medicine shortages: impact behind numbers [PDF]
Journal of Pharmaceutical Policy and Practice, 2023 Introduction Current research to assess the impact that medicine shortages have on patients is limited to general aspects, such as the prevalence of shortages and product characteristics.
Doerine J. Postma +4 more
doaj +8 more sources
Medicine Shortages in Serbia: Pharmacists’ Standpoint and Potential Solutions for a Non-EU Country [PDF]
Pharmaceutics, 2021 Medicine shortages in Serbia have evidently been present for several decades, but literature data are scarce. The aim of our study was to get an insight on the present situation in Serbia, review the EU actions when managing shortages, and discern a set ...
Nataša Jovanović Lješković +4 more
doaj +4 more sources
Impact of medicine shortages on patients - a framework and application in the Netherlands [PDF]
BMC Health Services Research, 2022 Background Medicine shortages are often described in plain numbers, suggesting all shortages have a uniform impact. However, some shortages have a direct and serious effect on patients and need a prompt reaction from stakeholders.
Doerine J. Postma +4 more
doaj +7 more sources
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications [PDF]
Frontiers in Pharmacology, 2020 IntroductionWhile medicine shortages are complex, their mitigation is more of a challenge. Prospective risk assessment as a means to mitigate possible shortages, has yet to be applied equally across healthcare settings.
Nenad Miljković +45 more
doaj +4 more sources
A multi-site repeated prevalence study of medicine shortages in community pharmacies [PDF]
Journal of Pharmaceutical Policy and PracticeBackground Medicine shortages are a global problem. Prior studies have focused on hospitals, and staff views, with less information on community practice.
John C. Hayden +5 more
doaj +4 more sources
Medicine Shortages: From Assumption to Evidence to Action - A Proposal for Using the FMD Data Repositories for Shortages Monitoring [PDF]
Frontiers in Medicine, 2021 Medicine shortages may negatively impact patient care and the patient experience. Shortages should be a priority of industry, supply chain stakeholders and national competent authorities, and deserve more than empathy or “lip-service” but serious ...
François Bouvy, Mihai Rotaru
doaj +4 more sources
Medicine Shortages: Gaps Between Countries and Global Perspectives [PDF]
Frontiers in Pharmacology, 2019 Introduction: Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of
Angela Acosta +11 more
doaj +10 more sources
Medicine shortages in Fiji: A qualitative exploration of stakeholders' views. [PDF]
PLoS ONE, 2017 ObjectivesMedicine access is a human right; yet, concerningly, there are international instances of shortages. Quantitative data has allowed WHO to propose global solutions; however, individualised understanding of specific regions is still required to ...
Josephine Walker +6 more
doaj +3 more sources
The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. [PDF]
PLoS ONE, 2017 The aim of this study was to explore the reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. The study took the form of semi-structured interviews.
Kati Heiskanen +4 more
doaj +3 more sources
Medicine shortages: Product life cycle phases and characteristics of medicines in short supply—A register study [PDF]
Frontiers in Pharmacology, 2022 Introduction: Product life cycle refers to all phases of a product from development to active market phase and finally the phase in which products possibly exit the market. The product life cycle of medicines in short supply has not been studied in depth,
Kati Sarnola, Heini Kari, Hanna Koskinen
doaj +2 more sources